Specialty pharmaceutical company Avenue Therapeutics, Inc. (ATXI) announced Thursday that it has reached final agreement with the U.S. Food and Drug Administration on the Phase 3 safety study protocol and statistical analysis approach, including the primary endpoint, for intravenous (IV) tramadol Tramadol is in development for the treatment of acute post-operative pain in a medically supervised setting.
India News: The National Pharmaceutical Pricing Authority has set the ceiling prices for nine drug formulations, including Tacrolimus and Co-trimoxazole. The pric
Find out what the most commonly prescribed pain medication in 2022 is according to Definitive Healthcare. Hydrocodone-acetaminophen tops the list of top 10 medi